Although we cannot completely exclude the bias of cofounding by indication that physicians may choose to prescribe insulin therapy for patients with more severe cirrhosis, our study suggested that in patients with compensated liver cirrhosis, the use of insulin warranted special attention. The gene discussed is INS; the disease is Cirrhosis.